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196Objective: The early postoperative period following neonatal cardiac surgery is a time of increased risk for brain
injury, yet the mechanisms underlying this risk are unknown. To understand these risks more completely, we
quantified changes in postoperative cerebral metabolic rate of oxygen (CMRO2), oxygen extraction fraction
(OEF), and cerebral blood flow (CBF) compared with preoperative levels by using noninvasive optical modal-
ities.
Methods: Diffuse optical spectroscopy and diffuse correlation spectroscopy were used concurrently to derive
cerebral blood flow and oxygen utilization postoperatively for 12 hours. Relative changes in CMRO2, OEF,
and CBF were quantified with reference to preoperative data. A mixed-effect model was used to investigate
the influence of total support time and deep hypothermic circulatory arrest duration on relative changes in
CMRO2, OEF, and CBF.
Results: Relative changes in CMRO2, OEF, and CBF were assessed in 36 patients, 21 with single-ventricle de-
fects and 15 with 2-ventricle defects. Among patients with single-ventricle lesions, deep hypothermic circula-
tory arrest duration did not affect relative changes in CMRO2, CBF, or OEF (P> .05). Among 2-ventricle
patients, total support time was not a significant predictor of relative changes in CMRO2 or CBF (P>.05), al-
though longer total support time was associated significantly with greater increases in relative change of post-
operative OEF (P ¼ .008).
Conclusions: Noninvasive diffuse optical techniques were used to quantify postoperative relative changes in
CMRO2, CBF, and OEF for the first time in this observational pilot study. Pilot data suggest that surgical duration
does not account for observed variability in the relative change in CMRO2, and that more comprehensive clinical
studies using the new technology are feasible and warranted to elucidate these issues further. (J Thorac Cardi-
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The Journal of Thoracic and Cardiovascular SurgThe past 3 decades have seen a dramatic increase in survival
rates of infants born with congenital heart defects (CHDs)
following surgical intervention. As a result, clinical focus
has shifted toward the short- and long-term neurologic se-
quelae that often accompany otherwise successful cardiac
repairs.1 Within 2 weeks after surgery, magnetic resonance
imaging studies have revealed that these infants have a re-
markably high (>50%) incidence of hypoxic–ischemic
white matter injury in the form of periventricular leukoma-
lacia,1-3 an elevated risk of stroke,4 and brain immaturity.2
By school age, children born with various forms of CHDs
often exhibit problems with academic achievement, fine
and gross motor function, visual–spatial skills, and execu-
tive function.1,5-8
The mechanisms underlying this increased perioperative
risk of brain injury and subsequent neurocognitive impair-
ments are not fully understood. However, evidence suggests
links between these impairments and increased cerebral
metabolic demands or decreased cerebral oxygen delivery
secondary to cardiopulmonary bypass (CPB) and/or deep
hypothermic circulatory arrest (DHCA), compromisedery c January 2013
Abbreviations and Acronyms
BFI ¼ blood flow index
CaO2 ¼ arterial oxygen concentration
CBF ¼ cerebral blood flow
CHD ¼ congenital heart defect
CICU ¼ cardiac intensive care unit
CMRO2 ¼ cerebral metabolic rate of oxygen
CPB ¼ cardiopulmonary bypass
DCS ¼ diffuse correlation spectroscopy
DHCA ¼ deep hypothermic circulatory arrest
DOS ¼ diffuse optical spectroscopy
D-TGA ¼ D-transposition of the great arteries
Hb ¼ deoxyhemoglobin
HbO2 ¼ oxyhemoglobin
Hgb ¼ arterial hemoglobin concentration
HLHS ¼ hypoplastic left heart syndrome
IQR ¼ interquartile range
NP ¼ nasopharyngeal
OEF ¼ oxygen extraction fraction
rCBF ¼ relative changes in cerebral blood flow
rCMRO2 ¼ relative changes in cerebral metabolic
rate of oxygen
rOEF ¼ relative changes in oxygen extraction
fraction
SaO2 ¼ arterial oxygen saturation
ScO2 ¼ cerebral tissue oxygen saturation
TST ¼ total surgical support
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Dcardiorespiratory function with hemodynamic instability
and hypoxemia, loss of cerebral autoregulation, and/or the
systemic inflammatory response to surgery.2,9 Several
reports have shown that longer duration of CPB and/or
DHCA may be linked with impaired neurocognitive
outcome3,6; however, other research has failed to find
similar links.2,4,7,8
Despite numerous studies suggesting a link between
increased postoperative metabolic demands and subse-
quent cerebral injury, quantification of cerebral meta-
bolic rate of oxygen (CMRO2) in neonates with CHDs
is limited, in large part because of technologic and
logistic challenges of these measurements. Pioneering
work by Greeley and colleagues10-13 demonstrated
that, after surgery, CMRO2 is suppressed in patients
undergoing DHCA but not in patients exposed to
moderate hypothermia, nor in patients exposed to
deep hypothermia with continuous flow. However, the
measurement of CMRO2 after return from the operating
room during the early postoperative period has not
yet been reported, nor has any connection between
postoperative CMRO2 and the support techniques used
during surgery.The Journal of Thoracic and CaTo address these clinical questions, we used diffuse opti-
cal spectroscopy (DOS) and diffuse correlation spectros-
copy (DCS) to monitor early postoperative changes in
CMRO2 compared with preoperative levels in neonates
with CHD with both single- and 2-ventricle cardiac
lesions, respectively. Furthermore, we investigated the po-
tential influence of the duration of total surgical support
time (TST) and/or DHCA on postoperative cerebral hemo-
dynamics resulting from changes in metabolic demands.
METHODS
Patient Population
This research is a prospective observational study. Inclusion/exclusion
criteria are described in Licht and colleagues.14 In brief, all otherwise
healthy full-term (ie, gestational age> 37 weeks) newborn infants with
complex CHDs admitted for surgical intervention with CPB were recruited
with institutional review board approval.
Surgical Strategies
Operations were performed by 3 cardiac surgeons and a team of
cardiac anesthesiologists. pH-stat blood gas management was used. In
general, during normothermic or mild hypothermic CPB (nasopharyn-
geal [NP] temperature > 28C), the pump flow rate was maintained
at 100 to 150 mL/kg/minute to achieve a mean arterial pressure
of 30 to 55 mm Hg. For deep hypothermic continuous CPB
(NP temperature< 22C), a pump flow rate of 25 to 50 mL/kg/minute
was used. Note, these general guidelines were modified as needed accord-
ing to the clinical situation. Deep hypothermic circulatory arrest was used
selectively at the surgeon’s discretion, not according to a predetermined
protocol. Before DHCA, patients underwent core and surface cooling
with topical hypothermia of the head to an NP temperature of
18C. Deep hypothermic circulatory arrest was used for all patients
undergoing stage 1 reconstruction for hypoplastic left heart syndrome
(HLHS) or HLHS variants. No patient received continuous antegrade
cerebral perfusion during the repair. The arterial switch operation and
other repairs of patients with 2-ventricle CHDs were performed with
continuous CPB. Modified ultrafiltration was performed in all patients
after CPB. Cerebral oximetry was not used to guide intraoperative
management.
Postoperative Management
Patients were monitored postoperatively in a dedicated cardiac inten-
sive care unit (CICU) with continuous electrocardiography, pulse oxime-
try, invasive arterial blood pressure transduction by radial or ulnar
catheterization, and right atrial pressure transduction by transthoracic
right atrial catheters, as well as intermittent arterial blood gas analysis
and bedside echocardiography as needed (ie, for hemodynamic instabil-
ity or desaturation). Arterial blood gas analyses were performed as part
of clinical care.
Cerebral Monitoring
Diffuse optical spectroscopy and diffuse correlation spectroscopy
(DOS and DCS, respectively) use near-infrared light to probe static and
dynamic optical properties of cortical brain tissue noninvasively. The
custom-made optical instrument used in this study combined fre-
quency–domain DOS with DCS on a mobile cart that is ideal for bedside
monitoring.15
Frequency–domain DOS (also known as near infrared spectroscopy) is
a widely accepted modality for measurement of cerebral oxy- and deoxy-
hemoglobin concentration ([HbO2] and [Hb], respectively). Frequency-do-
main DOS uses photon diffusion theory to relate the measured amplituderdiovascular Surgery c Volume 145, Number 1 197
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Dattenuation and phase shift of modulated, multiply scattered light detected
on the tissue surface to the wavelength-dependent absorption (ma) and scat-
tering (ms
0) properties of the probed tissue.16 Our DOS system (Imagent;
ISS, Inc, Champaign, Ill) used 8 laser diode sources modulated at 110
MHz and operating at 2wavelengths (688 nm and 826 nm), and a photomul-
tiplier tube detector with gain modulation of 110 MHzþ 5 kHz for hetero-
dyne detection at 5 kHz.
Diffuse correlation spectroscopy is a relatively new technology that has
been used to monitor cerebral blood flow (CBF) noninvasively. Diffuse cor-
relation spectroscopy monitors temporal fluctuations in the reflected light
intensity measured at points on the tissue surface. These temporal fluctua-
tions are caused primarily by photons that have been scattered by moving
red blood cells.16-18 Specifically, the temporal intensity autocorrelation
function of detected light is computed, and correlation diffusion theory16
is used to extract a tissue blood flow index (BFI, measured in square cen-
timeters per second). Previous studies in clinical and animal model systems
have shown that changes in BFI relative to a baseline are in agreement with
changes in CBF relative to a baseline measured by other gold standard CBF
techniques.15,16,19 The DCS instrument used in this work has been
described in detail elsewhere.15
The patient interface for this hybrid DOS/DCS instrument consisted of
a custom-made flexible black rubber probe (ISS, Inc) that was held manu-
ally against the patient’s forehead. This probe houses fiber optics for both
DOS and DCS. For DOS, we used 4 source-detector separations (1.5, 2.0,
2.5, and 3.0 cm), with 2 fibers (ie, one for each wavelength at each separa-
tion) and 1 detection fiber. For DCS, 8 single-mode detection fibers were
bundled and placed 2.5 cm away from the source fiber (on the tissue
surface).
Study Protocol
Diffuse optical and diffuse correlation spectroscopy measurements of
cerebral tissue oxygen saturation (ScO2, measured as a percentage) and
BFI were made multiple times on the day of surgery, both pre- and postop-
eratively. The measurement protocol and data analysis are described in de-
tail in Appendix 1. We defined t¼ 0 to be the time at which the patient was
taken off CPB support. Each patient had 1 measurement immediately prior
to surgery (typically around t¼4 hours) and 1measurement immediately
after patient return to the CICU after surgery (typically at t ¼ 1.5 hours);
multiple follow-up measurements were taken every 2 to 3 hours for the first
12 hours after surgery. During these brief measurement sessions, no venti-
lator changes were made during a session, blood loss was negligible, and
vital signs were stable.
Arterial oxygen saturation (SaO2, measured as a percentage) and hemo-
globin concentration (Hgb, measured in grams per deciliter) were calcu-
lated from clinically indicated arterial blood gases. These values were
used to compute oxygen extraction fraction (OEF), arterial oxygen concen-
tration (CaO2h 0.0134 3 SaO2 3 Hgb; measured in milliliters per deci-
liter), and CMRO2. Last, relative changes in postoperative OEF, CBF, and
CMRO2 (ie, rOEF, rCBF, and rCMRO2) from baseline (preoperative) levels
were computed so that each patient served as his or her own control
(see Appendix 1).
Statistical Analysis
For analysis purposes, patients were grouped according to cardiac de-
fect (ie, 1-ventricle vs 2-ventricle defects). Group 1 consisted of patients
with single-ventricle anatomy who received first-stage surgical pallia-
tion of HLHS and HLHS variants. Group 2 consisted of patients with
2-ventricle anatomy with D-transposition of the great arteries
(D-TGA). Intraoperative TST was defined as CPB plus DHCA duration.
To test for differences in patient characteristics between groups, we car-
ried out a Wilcoxon rank-sum test for continuous variables. To investi-
gate differences in postoperative systemic and cerebral hemodynamics
on return to the CICU from preoperative levels, we used a Wilcoxon
matched-pair test (for absolute measures such as SaO2, Hgb, etc)198 The Journal of Thoracic and Cardiovascular Surgand a Wilcoxon signed-rank test (for relative measures; ie, rCBF,
rOEF, and rCMRO2).
For patients in group 1, the effect of DHCA duration on the time pro-
files of rCMRO2, rCaO2, rCBF, and rOEF was examined using a linear
mixed-effect model with subject-specific random effects to account for
within-subject correlations resulting from repeated measures. The model
was used to predict the mean outcome variable (ie, rCMRO2, rCBF,
rCaO2, or rOEF) as a function of DHCA duration and time after removal
from CPB. Logarithmic transformation was applied to all outcome vari-
ables to make the data more normally distributed. A random slope and
intercept model was used for between-subject variation. Compound sym-
metry covariance structure, which assumed that correlations between all
pairs of measures within the same subject are the same, was used in the
mixed-effect model. A similar mixed-effect model was used in group 2 to
predict the mean outcome variable as a function of TST and as a function
of time after removal from CPB. All analyses were performed using SAS
9.3 statistical software (SAS Institute Inc, Cary, NC). Statistical signifi-
cance was declared for P values<.05.RESULTS
BetweenMarch 2010 and July 2012, 39 neonates were re-
cruited for study of pre- and postoperative cerebral hemody-
namics. One patient was excluded from the study because he
returned on extracorporeal membrane oxygenation; 2 pa-
tients were excluded because of poor pre- or postoperative
optical data quality. Thus, the remaining 36 patients were in-
cluded in our analysis. Group 1 consisted of 21 patients with
HLHS patients; group 2 consisted of 15 patients with
D-TGA. Of the 21 patients in group 1, 4 had aortic atresia/
mitral atresia (19%, 1 with intact atrial septum), 8 had aortic
atresia/mitral stenosis (38%, 1 with intact atrial septum), 6
had aortic stenosis/mitral stenosis (29%), 1 had a severely
unbalanced atrioventricular canal with arch hypoplasia
(5%), and 2 had double-outlet right ventricle with aortic
atresia/mitral stenosis (10%, 1 with a ventricular septal de-
fect). Nine of 15 patients with D-TGA (60%) had balloon
atrial septostomy performed 2 to 4 days prior to surgery.
Patient demographics are summarized in Table 1. Pa-
tients were born full term and went to surgery within the
first week of life. No differences in gestational age, birth
weight, day of life at surgery, or head circumference were
observed between groups. Median (interquartile range
[IQR]) surgical parameters, including CPB hematocrit,
temperature nadir, cooing time, TST, and DHCA duration,
are given in Table 2. The median intraoperative TST
for the entire cohort was 87 minutes (IQR, 70-116
minutes). No difference in TST was observed between
groups (P ¼ .62).
Preoperative systemic and cerebral parameters separated
by cardiac lesion are summarized in Table 3 (see also
Appendix E1). Patients with single-ventricle CHDs had sig-
nificantly higher SaO2 and CaO2 levels than those with
2-ventricle lesions (P< .001 and P ¼ .01, respectively).
No differences between groups were observed in preopera-
tive arterial Hgb, ScO2, or OEF. The median (IQR) of the
first postoperative value of each of these systemic andery c January 2013
TABLE 1. Summary of median (interquartile range) of demographic
patient characteristics
Variable Group 1 Group 2 P value
Gender, male:female; n 12:9 8:7 —
Gestation age, weeks 38.7 (38.0-39.4) 38.9 (38.0-39.1) .97
Birth weight, kg 3.2 (3.0-3.5) 3.4 (3.2-3.8) .09
Day of life 3 (2-5) 3 (3-4) .91
Head circumference, cm 33.6 (33.0-34.5) 34.1 (33.5-35.0) .13
AWilcoxon rank-sum test was used to test for significant differences between groups.
TABLE 3. Summary of median (interquartile range) pre- and first
postoperative systemic and cerebral hemodynamic variablesmeasured
CHD type Variable Preoperative Postoperative
P
value
One ventricle SaO2,% 88 (85-90) 74 (66-77) <.001
Hgb, g/dL 13.9 (13.3-14.6) 15.0 (14.0-15.7) .044
CaO2, mL/dL 16.2 (15.3-17.3) 14.4 (12.9-15.8) .006
ScO2,% 52 (43-59) 42 (38-46) .001
rOEF,% 100* 112 (76-162) .19
rCBF,% 100* 72 (39-100) .003
rCMRO2,% 100* 73 (33-96) .028
Two ventricles SaO2,% 78 (67-81) 99 (95-100) <.001
Hgb, g/dL 13.6 (12.3-15.2) 13.9 (12.3-15.2) .75
CaO2, mL/dL 13.2 (12.1-15.7) 18.3 (15.9-20.4) .002
ScO2,% 54 (48-55) 56 (45-62) .80
rOEF,% 100* 145 (107-222) .005
rCBF,% 100* 70 (40-90) .013
rCMRO2,% 100* 121 (59-207) .17
AWilcoxon matched-pair test was used for differences in SaO2, Hgb, CaO2, and ScO2
from before the operation to after the operation. A Wilcoxon signed-rank test was
used to test for changes in rOEF, rCBF, and rCMRO2 from preoperative levels.
CHD, Congenital heart defect; SaO2, arterial oxygen saturation; Hgb, hemoglobin;
ScO2, cerebral tissue oxygen saturation; CaO2, arterial oxygen concentration;
rOEF, relative change in postoperative oxygen extraction fraction; rCBF, relative
change in postoperative cerebral blood flow; rCMRO2, relative change in postopera-
tive cerebral metabolic rate of oxygen. *Each patient started at 100% and thus served
as his or her own control.
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Appendix E1). These data were obtained during normother-
mia and relative hemodynamic stability after the patient re-
turned to the CICU at a median time of 1.5 hours after
removal from CPB. For patients with single-ventricle le-
sions, SaO2, CaO2, and ScO2 decreased significantly from
preoperative values after surgery (P < .001, P ¼ .006,
P¼ .001, respectively). In addition, rCBF and rCMRO2 de-
creased after surgery (P ¼ .003 and P ¼ .03); in other
words, the medians for rCBF and rCMRO2 were both less
than 100% of preoperative values. For patients with
2-ventricle lesions, SaO2, CaO2, and rOEF increased signif-
icantly after surgery (P<.001, P ¼ .002, P ¼ .005, respec-
tively); rCBF decreased (P ¼ .01), and rCMRO2 did not
change (P ¼ .17) on average from preoperative levels.
Figures 1 and 2 show the relative changes in all outcome
variables (ie, rCMRO2, rCBF, rOEF, and rCaO2) from pre-
operative levels for patients with single- and 2-ventricle le-
sions, respectively. In both groups, the observed cerebral
hemodynamic changes after surgery were quite heteroge-
neous across individual patients. However, these figures
do suggest trends in the population average hemodynamic
responses to surgery, such as in Figure 1, D, in which
rCaO2 for single-ventricle patients appears to increase
from its preoperative level, which is in agreement with
the statistical test in Table 4.
Among patients with single-ventricle heart lesions, we
performed a mixed-effect model to assess the effects of
DHCA duration on our outcome variables using DHCA du-
ration and time after removal from CPB as model predic-
tors. The results of this analysis are summarized in Table
4. Deep hypothermic circulatory arrest duration did not
have a significant effect on changes in rCMRO2TABLE 2. Summary of median (interquartile range) of surgical
parameters
Variable Group 1 Group 2 P value
Hematocrit,% 30 (29-34) 31 (29-33) .66
Temperature nadir, C 17.6 (17.1-18.8) 33.7 (31.4-35.2) <.0001
Cooling time, min 17 (15-21) — —
Total support time, min 86 (74-102) 111 (53-138) .62
DHCA duration, min 44 (41-54) — —
AWilcoxon rank-sum test was used to test for significant differences between groups.
DHCA, Deep hypothermic circulatory arrest.
The Journal of Thoracic and Ca(P ¼ .45), rOEF (P ¼ .96), or rCBF (P ¼ .87) compared
with preoperative levels. However, longer DHCA durations
were associated significantly with a greater increase in post-
operative changes in rCaO2 from preoperative levels
(P ¼ .0001). In addition, of the 4 outcome variables, only
rCaO2 showed a significant increasewith time after removal
from CPB (P< .0001). Among several possible explana-
tions, this increase in rCaO2 with time may reflect the de-
gree of pulmonary inflammation or injury from prolonged
DHCA, with later recovery.
For patients with 2-ventricle CHDs, we used a mixed-
effects model to assess the effects of TST on our outcome
variables using TST and time after removal from CPB as
model predictors. The results of this analysis are summa-
rized in Table 4. Although longer TST is associated with
a greater increase in the change in rOEF (P ¼ .008), TST
did not affect changes significantly in rCMRO2 (P ¼ .29),
CBF (P¼ .47), or CaO2 (P¼ .73). In addition, of the 4 out-
come variables, only rCBF showed a significant increase
over time after removal from CPB (P ¼ .027).DISCUSSION
This work describes trends in optically measured
rCMRO2, rOEF, and rCBF after return to the CICU
after neonatal cardiac surgery (ie, during the first 12
hours after removal from bypass) for 2 distinct patient
groups—namely, those with single- and 2-ventricle cardiac
lesions, respectively. We note that multiple factors mayrdiovascular Surgery c Volume 145, Number 1 199
FIGURE 1. Time profiles of the relative change from preoperative levels in each outcome variable—rCMRO2 (A), rCBF (B), rOEF (C), and rCaO2 (D)—
after removal from CPB for all patients with single-ventricle lesions. The horizontal line indicates no change from preoperative levels. The x-axis (time) is
standardized between patients by setting t¼ 0 as the time the patient was taken off CPB. rCMRO2, Relative change in postoperative cerebral metabolic rate
of oxygen; rCBF, relative change in postoperative cerebral blood flow; rOEF, relative change in postoperative oxygen extraction fraction; rCaO2, relative
change in postoperative arterial oxygen concentration; CPB, cardiopulmonary bypass.
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D contribute to the postoperative time course of these param-
eters, including cardiac anatomy, cerebral autoregulation,
postoperative management, and postoperative physiology.
The current study suggests that, in future work, it will be
possible to investigate comprehensively more factors that
may explain intersubject variability in rCMRO2, rCBF,
and rOEF. With a larger sample size, the improved statisti-
cal power will permit critical examination of the effects of
systemic hemodynamics, surgical strategies, and postoper-
ative management.
In single-ventricle patients, we observed decreases in
CaO2, ScO2, rCBF, and rCMRO2 on return to the CICU
(at approximately 1.5 hours post-CPB, on average) from
preoperative levels. At this same time point for patients
with 2 ventricles, CaO2 and rOEF were increased from pre-
operative levels whereas CBF was decreased and CMRO2
was unchanged. Previous work from our laboratory sug-
gests that preoperative CBF is diminished compared with
healthy neonates, particularly in patients with HLHS.14
Thus, the observed decrease in CBF at the first postopera-
tive measurement may mean that CBF is deranged substan-
tially below the physiologic levels of a healthy neonate.
Because noninvasive optical imaging can be repeated
over time, changes in rOEF, rCBF, and rCMRO2 were mon-
itored further for an additional 12 hours after surgery, and
a mixed-effects model was used to assess trends with time.
For patients with a single ventricle, rCMRO2, rCBF, and200 The Journal of Thoracic and Cardiovascular SurgrOEF remained unchanged during the time period of post-
operative monitoring. For patients with 2 ventricles, rCBF
increased significantly with time after removal from CPB,
whereas rCMRO2 and rOEF remained unchanged during
the time period of postoperative monitoring.
During surgery, these patients encounter various degrees
of hypothermia, low or no cerebral perfusion, and exposure
of the blood to synthetic surfaces of the bypass machine.
These profound surgical interventions have been investi-
gated extensively as risk factors for poor neurodevelop-
mental outcomes, although results from different studies
have been contradictory, and clear associations have
not been proved.2-4,6-8 In this study, the duration of
these exposures fails to explain trends in cerebral
hemodynamic and metabolic measurements after surgery.
Using a mixed-effect model, we found that longitudinal
postoperative changes in rCMRO2 from preoperative levels
were independent of DHCA duration (group 1, single ven-
tricle) and TST (group 2, 2 ventricles). We chose to in-
clude only DHCA duration in our model for group 1
because we found that DHCA duration was highly corre-
lated with TST (Pearson correlation coefficient,
R ¼ 0.81; P< .0001). Including 2 highly correlated vari-
ables into a mixed-effects model can lead to colinearity.
For group 1, DHCA duration was also not a statistically
significant predictor of rOEF or rCBF; however, a signifi-
cant effect of both time after removal from CPB andery c January 2013
FIGURE 2. Time profiles of the relative change from preoperative levels in each outcome variable—rCMRO2 (A), rCBF (B), rOEF (C), and rCaO2 (D)—
after removal from CPB for all patients with 2-ventricle lesions. The horizontal line indicates no change from preoperative levels. The x-axis (time) is stan-
dardized between patients by setting t ¼ 0 as the time the patient was taken off CPB. rCMRO2, Relative change in postoperative cerebral metabolic rate of
oxygen; rCBF, relative change in postoperative cerebral blood flow; rOEF, relative change in postoperative oxygen extraction fraction; rCaO2, relative
change in postoperative arterial oxygen concentration; CPB, cardiopulmonary bypass.
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changes in pulmonary physiology that are extrinsic to ce-
rebral physiology. For group 2, TST was not a significant
predictor of rCBF or rCaO2; however, rOEF increased sig-
nificantly with increasing TST.
To our knowledge, the literature investigating CMRO2
and CBF after CPB surgery in human neonates with
CHD comes from a single research group. Greeley and col-
leagues10-13 investigated the immediate effects of cooling
and circulatory arrest on CMRO2 in patients with CHD
ranging in age from 1 day to 14 years old using arterial
and jugular blood samples combined with 133Xe
clearance techniques for CBF measurements. They
quantified CBF and CMRO2 in the operating room
before CPB, and again after rewarming and removal
from CPB. Although many differences exist between the
2 studies, the most significant differences are timing of
the measurements and the average age of the cohorts.
The average age of patients in the moderate hypothermia
group of Greeley and colleagues10-13 was 65 months
compared with 3 days in group 2 of our cohort. Despite
these substantial differences in cohorts and measurement
timing, patients in their studies who received DHCA
(similar to group 1 in our cohort) had, on average,
significantly lower CMRO2 levels after surgery compared
with preoperative levels; by contrast, patients who
received continuous-flow CPB with moderate hypothermiaThe Journal of Thoracic and Ca(similar to group 2 in our cohort) had postoperative
CMRO2 that, on average, returned to preoperative levels.
12
These population-averaged CMRO2 results are very simi-
lar to the results observed herein.
The majority of literature on postoperative cerebral mon-
itoring in these patients has centered on the use of either
near-infrared spectroscopy to monitor trends in regional
ScO2
2,20 or the use of mixed venous oxygen saturations
from the superior vena cava.9,21,22 Our results of ScO2
both before surgery and on return to the CICU for
patients with 1 ventricle (Table 3) are lower than previously
reported,2,20 potentially because of differences in the
optical measurement techniques.
Study Limitations
The results presented herein have several limitations. The
most important limitation is the lack of a direct comparison
group to determine the effects of DHCA versus no DHCA.
Ideally, comparison should be performed on patients with 1
ventricle, half of whom have surgery with the use of DHCA
and half of whom have continuous regional cerebral perfu-
sion. This comparison would necessitate a multicenter
study because surgeons in individual centers are highly
biased to surgical technique.
Furthermore, the postoperative changes in rCMRO2,
rOEF, and rCBF presented herein are indicative only of
the superficial frontal cortex, as the optical techniquesrdiovascular Surgery c Volume 145, Number 1 201
TABLE 4. Results of the mixed-effect model using time after removal
from cardiopulmonary bypass and deep hypothermic circulatory
arrest duration (for single-ventricle patients) or total support time
(for 2-ventricle patients) as predictors for outcome measurements
CHD type
Outcome
variable
Model
predictor
Estimate (SE)
of coefficient
P
value
One ventricle rCMRO2 Time, h 0.022 (0.025) .42
DHCA, min 0.007 (0.009) .45
rOEF Time, h 0.003 (0.015) .84
DHCA, min 0.0002 (0.005) .96
rCBF Time, h 0.003 (0.021) .87
DHCA, min 0.001 (0.007) .87
rCaO2 Time, h 0.031 (0.006) <.0001
DHCA, min 0.009 (0.002) .0001
Two ventricles rCMRO2 Time, h 0.045 (0.030) .16
TST, min 0.003 (0.003) .29
rOEF Time, h 0.014 (0.014) .31
TST, min 0.003 (0.001) .008
rCBF Time, h 0.046 (0.019) .027
TST, min 0.001 (0.002) .47
rCaO2 Time, h 0.011 (0.009) .26
TST, min 0.0003 (0.0007) .73
Logarithm transformations were used on all outcome variables to make the data more
normally distributed. Coefficient estimates are reported along with SE. CHD, Con-
genital heart defect; SE, standard error; rCMRO2, relative change in the cerebral met-
abolic rate of oxygen; DHCA, deep hypothermic circulatory arrest; rOEF, relative
change in postoperative oxygen extraction fraction; rCBF, relative change in postop-
erative cerebral blood flow; rCaO2, relative change in postoperative arterial oxygen
concentration; TST, total support time.
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der the optical probe. Thus, we cannot make claims on
CMRO2, OEF, or CBF in the rest of the brain. In addition,
the optical measurements were not performed beyond 12
postoperative hours because of manpower restrictions. Fu-
ture work would benefit from measurements taken over
multiple locations on the head for up to 48 hours after re-
moval from CPB.
To date, rCMRO2 as measured by DOS and DCS has not
been validated against any gold standard CMRO2 tech-
niques. However, the input variables (ie, rOEF and rCBF)
used to derive our computation of rCMRO2 have been
well validated in both animal and human models.15,19
Nevertheless, several sources of error are inherent in the
estimation of rCMRO2 and are described in detail in
Culver and associates.23
Given the sample size in group 1 (n ¼ 21) and the ob-
served effect size of DHCA on rCMRO2, the study power
is 83% at a significance level of 0.05, assuming a compound
symmetric correlation structure and a Pearson correlation
coefficient of 0.5 between 2 measures within the same sub-
ject. This suggests that our study is slightly underpowered
to detect the effects of DHCA duration on rCMRO2. How-
ever, given the sample size of group 2 (n ¼ 15) and the ob-
served effect size of TST on rCMRO2, the study power is
greater than 90%.202 The Journal of Thoracic and Cardiovascular SurgCONCLUSIONS
We have quantified changes noninvasively in rCMRO2,
rCBF, and rOEF for 12 hours after infant cardiac surgery us-
ing DOSs in a prospective observational pilot study. We
found that, despite exposures to extremes of temperature
and synthetic surfaces during surgery, neither TST nor
DHCA duration was a significant predictor of postoperative
changes in rCMRO2 compared with preoperative levels.
This work takes a useful step by quantifying the time courses
of cerebral hemodynamics after surgery, fromwhichwemay
discover the origin of impaired neurocognitive outcome. Fu-
turework will investigate the utility of rCMRO2 in assessing
risk factors and timing of postoperative brain injury.
We thank the CICU nurses and respiratory therapists, as well as
the patients and families for their participation.References
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DAPPENDIX 1.
Each optical measurement session lasted approximately
10 to 15 minutes. Cerebral hemoglobin concentrations
([HbO2] and [Hb]) and BFI were measured sequentially
over the right and left frontal cortex with DOS and DCS,
for a total of 4 measurements over each hemisphere. To en-
able the measurement of absolute [Hb] and [HbO2], DOS
data were also collected on a solid phantom with known op-
tical properties during every optical measurement session.
The phantom data facilitated calculation of the coupling co-
efficients between optical fibers and tissue.24
Diffuse optical spectroscopy data were analyzed using
the semi-infinite solution to the photon diffusion equation
for a homogeneous medium. The phase and AC amplitude
(AC) of the detected light are used to quantify the optical
properties of the tissue. Specifically, the slope of
phase versus source-detector separation (r) and the slope
of ln(AC 3 r2) versus r were determined and used to com-
pute tissue absorption and scattering coefficients: ma(l) and
ms
0(l), respectively.16 Data were discarded if these linear fits
had a Pearson R2< 0.975. In the near infrared, tissue ab-
sorption in brain tissue is primarily a result of [HbO2],
[Hb], and water:
maðlÞ ¼ εHbO2ðlÞ½HbO2þεHbðlÞ½Hbþ0:75ma;H2OðlÞ: [1]
Here, εHbO2ðlÞ and εHb(l) are the known wavelength ex-
tinction coefficients of HbO2 and Hb, respectively,The Journal of Thoracic and Cama;H2OðlÞ is the absorption of pure water at wavelength l,
and we have assumed that the brain tissue volume is approx-
imately 75% water. We reconstructed average [Hb] and
[HbO2] from tissue absorption measurements at 2 wave-
lengths (688 nm and 826 nm) via the system of 2 equations
generated by Eq. 1. From [Hb] and [HbO2], we derived
ScO2: ScO2h [HbO2]/([Hb]þ [HbO2])3 100%. Cerebral
tissue oxygen saturation was calculated for each of the 8
measurements taken during the measurement session.
These 8 values were then averaged together to quantify
a mean ScO2 at each measurement time point.
For DCS, each measured intensity autocorrelation func-
tion was fit to obtain a BFI using the semi-infinite solution
to the correlation diffusion equation for a homogenous me-
dium.16,17 The measurements of BFI from the right and left
cortex were averaged together to quantify mean BFI for
each measurement time point. Note that the tissue optical
properties ma and ms
0 at the DCS wavelength (785 nm) are
required inputs to the fit for BFI. Although we only
measured these coefficients at 688 nm and 826 nm,
we were able to derive ma(785 nm) using measured
[Hb] and [HbO2] along with the known Hb and
HbO2 extinction coefficients at 785 nm using Eq. 1. To de-
rive ms
0(785 nm), we assumed a power-law wavelength
dependence for ms
0(l) (ie, ms0(l) ¼ Alb), where A and
b depend on the size and number of scatters.25
The data acquired from DOS and DCS—namely, ScO2
and BFI—were combined to give a measure of change in
CMRO2 by using a steady-state compartmental model of
oxygen exchange between capillaries and tissue, which
has been derived and discussed in detail elsewhere.16,23
Within this model, the relative change in CMRO2
(or rCMRO2) at time t relative to the preoperative value is
rCMRO2ðtÞ ¼ rCBFðtÞ3rCaO2ðtÞ3rOEF3100%: [2]
Here, rCBF(t)h BFI(t)/BFIpre is the relative change in
postoperative BFI measured at time t from the preoperative
BFI value, rCaO2(t) h CaO2(t)/ CaO2pre is rCaO2, and
rOEFh (SaO2(t) – ScO2(t))/(SaO2 – SaO2)pre 3 SaO2pre/
SaO2 (t) is rOEF. The subscript pre is used to indicate the
preoperative measurement. Note that 2 terms contribute to
the final estimate of rCMRO2: relative change in oxygen de-
livery to tissue (rDO2h rCBF(t) 3 rCaO2(t) and relative
change in oxygen extraction.Discussion
Dr Christian Pizarro (Wilmington, Del). Dr Licht and col-
leagues have presented an important work using a novel and non-
invasive technique to monitor early postoperative changes in
cerebral metabolic rate compared with preoperative levels in a co-
hort of neonates undergoing cardiac surgery. For this purpose they
evaluated 30 newborn children who underwent either the Norwood
procedure or biventricular repair during the first week of life.rdiovascular Surgery c Volume 145, Number 1 203
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rial oxygen content, and ScO2 from preoperative values in the sin-
gle-ventricle subgroup, to some extent possibly influenced by
reflection of controlled pulmonary blood flow and decrease in
Qp/Qs.
In addition, CBF and CMRO2 were decreased, which reaffirms
previous observations on the delayed recovery of CBF after
DHCA. On the other hand, patients undergoing 2-ventricle repair
exhibited an appropriate increase in CaO2 and content, and a de-
crease in CBF from preoperative levels, whereas extraction was in-
creased significantly, which leads me to the first question.
I noticed in your slide that patients in the 2-ventricle group were
extubated early after surgery. What percentage of these patients
were extubated or in a weaning mode from mechanical ventilation
at the time the first measurement was taken, which I understand
was about 1.5 hours after separation from bypass? It is possible
that some of the difference observed could be influenced by the
different patient conditions at the time measurement was taken.
In addition, were there any significant differences in temperature
between the single-ventricle and the 2-ventricle groups?
Dr Licht. Patients with 2-ventricle repairs were extubated soon
after return to the CICU from the operating room. In about half,
extubation was delayed and we were able to make the initial mea-
surement under conditions of mechanical ventilation; in the other
half, extubation delayed our making our first measurement, but I
don’t have those numbers separated for you right now.
In terms of temperature, they were all the same temperature on
arrival. I believe the protocol is separation from bypass at 35C and
patients are all rewarmed to 36.5C on return to the CICU.
Dr Pizarro. Second, evidence suggests that cerebral vascular
autoregulatory mechanisms are dysfunctional after circulatory ar-
rest, resulting in an increased cerebrovascular resistance and de-
creased CBF. Moreover, the absence of a vasodilatory response
to hypoxemia leaves the cerebral circulation vulnerable to changes
in perfusion pressure and oxygen content in the blood. To deter-
mine the potential influence of hemodynamics on these measure-
ments, can you tell us a little bit about some hemodynamic
measurements of these patients at the time these calculations
were made—for example, arterial blood pressure during the post-
operative period?
Dr Licht. Our plan is to make correlations between the optical
measurements and multiple vital sign measurements during this
postoperative period. We use a CNS-100 Multimodal Neuromoni-
tor (CNS Technology, LLC, Ambler, Pa) to capture all vital
signs in real time off of the CNS-100 monitor through the
serial port.
The optical instruments are made continuously, so we have lon-
gitudinal measurements captured in real time that are time-locked
with continuous vital sign measurements. The data are quite com-
plex and the database is quite large. We are working closely with
an engineering group to develop new ways to look at the data. So
far we have looked at 2-input time series analysis between blood
flow and mean arterial blood pressure, and we do note that there
are considerable periods of time when autoregulation is disrupted.
However, if blood pressure is held constant for a long period of
time, it’s hard to know whether autoregulation is actually intact
or disrupted, so we have to figure out how to analyze these data.
We hope to have meaningful results available soon.204 The Journal of Thoracic and Cardiovascular SurgDr Pizarro. Third, the arterial oxygen content in single-ventri-
cle patients is probably influenced by several elements, including
mixed venous oxygen saturation. Although I would agree that im-
proving the lung function is one possible explanation for the obser-
vation of an increase during the postoperative period; however,
a blood sample from pulmonary veins would be required to sup-
port this assertion. Increased arterial oxygen content in these pa-
tients, therefore, could be a reflection of changes in cardiac
output during the postoperative period. Do you have any measures
on the status of the systemic perfusion, like amixed venous oxygen
saturation trend or lactate levels, or this is part of probably the
analysis that, in theory, would come in the future?
Dr Licht. Measurements of mixed venous saturations and car-
diac output are not part of the research protocol and are routinely
collected clinically in all patients. However, we do have a way of
separating out the venous component of our cerebral oxygen satu-
ration measurements. And if you gate the instrument to respiratory
rate for those patients that are still mechanically ventilated, you
can do a Fourier transform of the optical data and find the venous
saturations in the brain.
Dr Pizarro. Fourth, experimental data in animals suggests that
impairment in cerebral metabolism is directly related to the dura-
tion of circulatory arrest. You have shown us that CMRO2 was not
affected by the duration of circulatory arrest. Can you provide your
insight about the reason for this observation?
Dr Licht. That’s a more difficult question and purely specula-
tive. I believe that the brain is fully protected during that period
of deep hypothermia. We do not measure metabolic recovery dur-
ing rewarming from low temperatures that occurs within the oper-
ating room. Our measurements are made after the babies are
returned to the CICU, a full 1.5 hours after separation from bypass.
Time of measurement is important, and it is possible that the differ-
ences in CMRO2measurements are related to this. It’s our intention
to develop an optical instrument that can measure brain tempera-
ture so that we can correlate temperature with return of CMRO2.
Dr Pizarro. Noninvasive assessment of CMRO2 in real time
can be a very important contribution to understanding the impact
of management strategies on the cerebral circulation and its effects
on neurodevelopmental outcome. I congratulate you and your col-
leagues on this very exciting work and look forward to learning
more from your future analysis.
Dr Richard Gates (Orange, Calif). A perfusion technique
question: It’s clear in the hypoplast group that you were using
circulatory arrest and deep hypothermia. In the transposition
group, is it safe to assume these patients were at full flow—say,
32C—CPB?
Dr Licht. Correct.
Dr Gates. Then, apart from the other influencing factors, such
as oxygen saturation and level of anesthesia, do you believe that
the technique of more normothermic bypass may be the rea-
son—as opposed to using circulatory arrest—that you saw these
more favorable cerebral measurements in the transposition group?
Dr Licht. Well, it’s very hard to separate because of the dif-
ferences in anatomy between the 2 groups. The babies with the
transposition have a corrected heart and complete separation of
the arterial and venous circulations, so I believe the differences
are reflective of improved arterial saturations in this population.
A better comparison would be comparing infants with HLHSery c January 2013
Buckley et al Congenital Heart Diseasewho receive surgery with DHCA and infants with HLHS who
receive surgery with deep hypothermic antegrade flow with cir-
culatory arrest, and we are looking for collaborations for that
study.
Dr Gates. Yes, I would think it would be a very good study. Our
group has been performing our Norwoods using continuousThe Journal of Thoracic and Canormothermia selective cerebral perfusion for>7 or 8 years and
have been very pleased with the neurologic outcomes. It would
be very interesting to compare a continuous selective normother-
mic group versus the DHCA group versus the deep hypothermia
with selective perfusion group, with regard to these cerebral issues.
Thank you for an excellent presentation.rdiovascular Surgery c Volume 145, Number 1 205
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TABLE E1. Summary of median (interquartile range) pre- and first postoperative systemic hemodynamic variables measured
CHD type Variable Preoperative Postoperative P value
Single-ventricle pH 7.38 (7.34-7.40) 7.44 (7.41-7.48) .014
pCO2, mm Hg 40 (37-43) 39 (36-45) .99
pO2, mm Hg 53 (43-61) 37 (34-41) <.0001
Hct,% 41 (39-44) 44 (40-45) .08
HR, bpm 155 (138-160) 153 (145-165) .15
MAP, mm Hg 58 (52-66) 52 (46-56) .09
SpO2,% 92 (87-95) 83 (80-85) .004
RAP, mm Hg — 8 (5-9) —
Temperature, C 37.1 (36.7-37.3) 36.0 (35.6-36.4) .0003
Two ventricles pH 7.39 (7.38-7.41) 7.50 (7.45-7.58) .003
pCO2, mm Hg 40 (36-42) 40 (34-45) .65
pO2, mm Hg 41 (35-45) 106 (83-285) <.0001
Hct,% 39 (36-44) 41 (36-45) .96
HR, bpm 141 (138-155) 159 (138-177) .032
MAP, mm Hg 68 (54-70) 63 (61-68) .99
SpO2,% 85 (78-90) 96 (95-99) .012
RAP, mm Hg — 6 (5-7) —
Temperature, C 37.3 (37-37.5) 36.2 (36.0-37.0) .014
AWilcoxon matched-pair test was used for differences from before the operation to after the operation. Note, RAP was not measured preoperatively. CHD, Congenital heart
defect; pCO2, partial pressure of carbon dioxide; pO2, partial pressure of oxygen; Hct, hematocrit; HR, heart rate; bpm, beats per minute; MAP, mean arterial pressure;
SpCO2, transcutaneous oxygen saturation; RAP, right atrial pressure.
APPENDIX E1.
Pre- and first postoperative arterial blood gas data (pH, par-
tial pressure of carbon dioxide [pCO2], partial pressure of
oxygen [pO2], and hematocrit) as well as systemic vital
sign parameters (heart rate [HR], mean arterial pressure
[MAP], transcutaneous oxygen saturation [SpO2], right
atrial pressure, and temperature) separated by cardiac lesion
are summarized in Table E1. The preoperative data were ob-
tained immediately before surgery during the optical mea-
surements of cerebral hemodynamics. Postoperative
data were obtained during normothermia and relative
hemodynamic stability after the patient returned to the car-
diac intensive care unit at a median time of 1.5 hours after
removal from cardiopulmonary bypass. For both types of
cardiac lesion, pH increased significantly after surgery
from preoperative values and pCO2 remained relatively
constant. For patients with 2-ventricle lesions, pO2 and
SpO2 increased significantly after surgery, whereas for pa-
tients with 1 ventricle pO2 and SpO2 decreased significantly
on average. Postoperatively, HR increased slightly in the
single-ventricle group, and MAP remained unchanged in
both groups.
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